Two Sigma Investments’s MBX Biosciences MBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.57M Sell
112,075
-1,400
-1% -$87.7K ﹤0.01% 1904
2026
Q2
$6.26M Sell
113,475
-1,600
-1% -$55.9K ﹤0.01% 1929
2026
Q1
$3.43M Sell
115,075
-23,496
-17% -$799K ﹤0.01% 2322
2025
Q4
$4.37M Buy
138,571
+124,984
+920% +$3.03M 0.01% 1835
2025
Q3
$238K Buy
+13,587
New +$182K ﹤0.01% 3314
2025
Q2
– Sell
-33,833
Closed -$250K – 3624
2025
Q1
$250K Buy
+33,833
New +$358K ﹤0.01% 2787

Other funds holding MBX

Two Sigma Investments's MBX Position: Q3 2026 in Review

Two Sigma Investments reduced its MBX Biosciences (MBX) stake by 1.2% in Q3 2026, selling an estimated $87.7K and leaving 112,075 shares worth $6.57M. The position accounts for ﹤0.01% of the portfolio, ranked #1904.

Two Sigma Investments first reported a position in MBX in Q1 2025 and has held it in 6 quarters since. 189 funds tracked by Wall St. Rank hold MBX as of Q3 2026.

  • Two Sigma Investments held 112,075 shares of MBX Biosciences worth $6.57M as of Q3 2026.
  • Two Sigma Investments sold 1,400 MBX Biosciences shares in Q3 2026, an estimated $87.7K.
  • MBX Biosciences made up ﹤0.01% of Two Sigma Investments's portfolio in Q3 2026, its #1904 holding.
  • Two Sigma Investments first reported a position in MBX Biosciences in Q1 2025 and has held it in 6 quarters since.
  • 189 funds tracked by Wall St. Rank held MBX Biosciences as of Q3 2026.

Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.